Platinum Series Alpha Protocol
Natural health product licensed in Canada
- Licence holder
- Bodybuilding.com, LLC
- NPN or DIN-HM
- 80057326
- Status
- Active licence
- Licence date
- 15 January 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Trigonella foenum-graecum Source : Trigonella foenum-graecum - Graine Extract : Matériel brut sec Extraction ratio : 33:1 Dry plant equivalent : 3.3 g | 100 mg | Not calculated |
| Zinc Source : Citrate de zinc | 5 mg | 5,000 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 1.76 mg | 1,760 µg |
| Acide D-aspartique Source : Acide D-aspartique | 520 mg | Not calculated |
| Magnésium Source : Citrate de magnésium | 5.67 mg | 5,670 µg |
| Eurycoma longifolia Source : Racine Extraction ratio : 100:1 Dry plant equivalent : 1,667 mg Potency : 0.17 mg Eurycomanone | 16.67 mg | Not calculated |
| Eurycoma longifolia Source : Racine Potency : 22 % Eurypeptides | Not specified | Not calculated |
| Eurycoma longifolia Source : Racine Potency : 1 % Eurycomanone | Not specified | Not calculated |
| Eurycoma longifolia Source : Racine Potency : 40 % Glycosaponins | Not specified | Not calculated |
| Eurycoma longifolia Source : Racine Potency : 3.67 mg Eurypeptides | Not specified | Not calculated |
| Eurycoma longifolia Source : Racine Potency : 6.67 mg Glycosaponins | Not specified | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help reduce elevated blood lipid levels/hyperlipidemia. (Traditionally) used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. (Traditionally) used in Herbal Medicine to help stimulate the appetite. (Traditionally) used in Herbal Medicine as a digestive tonic to aid digestion. (Traditionally) used in Herbal Medicine to help relieve dyspepsia and gastritis. Used in Herbal Medicine as a mild laxative. Traditionally used in Herbal Medicine as an expectorant to help relieve excess mucous of the upper respiratory passages (anti-catarrhal). (Traditionally) used in Herbal Medicine as a nutritive tonic. A factor in the maintenance of good health. Helps in tissue formation. Helps the body to metabolize carbohydrates, fats and proteins. Helps in connective tissue formation. Helps to maintain healthy skin. Helps to maintain immune function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80057326
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.